NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW 1,618.00
-12.00 (-0.74%)
Mar 20, 2025, 9:00 AM KST
NGeneBio Revenue
In the year 2024, NGeneBio had annual revenue of 5.69B KRW with 30.80% growth. NGeneBio had revenue of 716.54M in the quarter ending December 31, 2024, a decrease of -40.39%.
Revenue
5.69B
Revenue Growth
+30.80%
P/S Ratio
3.23
Revenue / Employee
88.23M
Employees
70
Market Cap
30.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.69B | 1.34B | 30.80% |
| Dec 31, 2023 | 4.35B | -6.67B | -60.51% |
| Dec 31, 2022 | 11.02B | 3.85B | 53.81% |
| Dec 31, 2021 | 7.16B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition